P55072 (TERA_HUMAN) Homo sapiens (Human)

Transitional endoplasmic reticulum ATPase UniProtKBInterProSTRINGInteractive Modelling

806 aa; Sequence (Fasta) ; 42 identical sequences

Available Structures

125 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Cryo-EM structure of human p97 in complex with Npl4/Ufd1 and polyubiquitinated Ub-Eos (FOM, Class 2) Heteromer
12-775
99.73ADP;ATP;MG;
Cryo-EM structure of human p97 in complex with Npl4/Ufd1 and polyubiquitinated Ub-Eos (FOM, Class 3) Heteromer
12-775
99.73ADP;ATP;MG;
Cryo-EM structure of human p97 in complex with Npl4/Ufd1 and polyubiquitinated Ub-Eos (CHAPSO, Clas… Heteromer
12-775
99.73ADP;ATP;MG;
Cryo-EM structure of human p97 in complex with Npl4/Ufd1 and polyubiquitinated Ub-Eos (FOM, Class 1) Heteromer
12-775
99.73ADP;ATP;MG;
Cryo-EM structure of human p97 in complex with Npl4/Ufd1 and polyubiquitinated Ub-Eos (CHAPSO, Clas… Heteromer
12-775
99.73ADP;ATP;MG;
Cryo-EM structure of P97-VCPIP1 complex Heteromer
Q96JH7;
12-775
100
p47-bound p97-R155H mutant with ATPgammaS Heteromer
O35987;
15-772
99.8612×AGS;
p47-bound p97-R155H mutant with ADP Heteromer
O35987;
18-774
99.8612×ADP;
The cryo-EM structure of human ERAD retro-translocation complex Heteromer
Q9BUN8;
22-776
100ATP;ADP;
The cryo-EM structure of human ERAD retro-translocation complex Heteromer
Q9BUN8;
22-776
100ADP;
The cryo-EM structure of human ERAD retro-translocation complex Heteromer
Q9BUN8;
22-776
10012×ADP;
p97 variant 2 in the apo state Heteromer
21-774
99.4512×SO4;
p97-p37-SPI substrate complex Heteromer
P36873; Q14CS0; Q15435;
21-773
100
p97-delta709-728 in complex with a UFD1-SHP peptide Heteromer
Q92890;
21-770
100.012×AGS; 12×MG;CL;GOL;
Quantitative interaction mapping reveals an extended ubiquitin regulatory domain in ASPL that disru… Heteromer
Q9BZE9;
13-760
100.0ADP;
Cryo-EM structure of p97:UBXD1 meta state Heteromer
Q9BZV1;
23-763
100.012×ADP;
Cryo-EM structure of p97:UBXD1 PUB-in state Heteromer
Q9BZV1;
23-763
100.012×ADP;
Cryo-EM structure of p97:UBXD1 para state Heteromer
Q9BZV1;
23-763
100.012×ADP;
Cryo-EM structure of p97:UBXD1 open state Heteromer
Q9BZV1;
23-763
100.012×ADP;
Cryo-EM structure of p97:UBXD1 closed state Heteromer
Q9BZV1;
23-763
100.012×ADP;
Cryo-EM structure of p97:UBXD1 VIM-only state Heteromer
Q9BZV1;
23-763
100.012×ADP;
Cryo-EM structure of p97:UBXD1 lariat mutant Heteromer
Q9BZV1;
23-763
100.012×ADP;
Cryo-EM structure of p97:UBXD1 H4-bound state Heteromer
Q9BZV1;
23-763
100.012×ADP;
Structure of human p97 ATPase L464P mutant Heteromer
25-763
99.86ADP;
Structure of p97 (subunits A to E) with substrate engaged Heteromer
198-766
100.010×ADP;BEF;MG;
Quantitative interaction mapping reveals an extended ubiquitin regulatory domain in ASPL that disru… Heteromer
Q9BZE9;
21-480
100.0ADP;MG;SO4;EDO;GOL;
p97 ND1-A232E in complex with VIMP Heteromer
Q9BQE4;
10-460
99.78ANP;MG;
p97 ND1-L198W in complex with VIMP Heteromer
Q9BQE4;
14-460
99.77ANP;MG;
Crystal structure of AAA ATPase p97/VCP ND1 in complex with p47 C Heteromer
O35987; Q01853;
18-458
99.77ADP;
Common mode of remodeling AAA ATPases p97/CDC48 by their disassembly cofactors ASPL/PUX1 Heteromer
Q9LK22;
23-462
100ADP;
Structural basis for targeted p97 remodelling by ASPL as prerequisite for p97 trimethylation by MET… Heteromer
Q9BZE9; Q9H867;
23-461
100.0EDO;ATP;MG;SAH;
Crystal structure of p97-N/D1 hexamer in complex with FAF1-UBX domain Heteromer
Q9UNN5;
21-458
99.3112×ADP;
Crystal structure of the p97-N/D1 hexamer in complex with six p47-UBX domains Heteromer
Q9UNZ2;
22-458
99.5412×ADP;
Crystal structure of p97 N/D1 in complex with a valosin-containing protein methyltransferase Heteromer
Q9H867;
23-458
100.0SAH;GOL;FMT;ACT;ADP;EPE;
Strctural Model of the p97 N domain- npl4 UBD complex Heteromer
P60670; Q01853;
21-213
99.48
Crystal structure of p97-N in complex with FAF1-UBX Heteromer
Q9UNN5;
10-186
100CL;
Crystal structure of FAF1 UBX-p97N-domain complex Heteromer
Q9UNN5;
23-199
100
Crystal structure of p97/VCP N in complex with OTU1 UBXL Heteromer
P43558;
23-196
100
Structural Details of Ufd1 binding to p97 Heteromer
Q92890;
21-191
100
Structural Insights into the Interaction of p97 N-terminus Domain and VBM Motif in Rhomboid Proteas… Heteromer
Q8TEB9;
21-190
100
Crystal Structure of FAF1 UBX Domain In Complex with p97/VCP N Domain Reveals The Conserved FcisP T… Heteromer
Q9UNN5;
23-192
100
Structural insights into the interaction of p97 N-terminal domain and SHP motif in Derlin-1 rhomboi… Heteromer
Q9BUN8;
23-192
100
Crystal structure of the UBX domain of human UBXD7 in complex with p97 N domain Heteromer
O94888;
23-191
100
Crystal structure of p97N in complex with the C-terminus of gp78 Heteromer
Q9UKV5;
22-186
100.0CL;
Crystal structure of p97/VCP N in complex with OTU1 UBXL Heteromer
P43558;
21-185
100.0
PLAP/P97 complex Heteromer
Q9Y263;
803-806
100MG;
Crystal structure of HOIP PUB domain in complex with p97 PIM Heteromer
Q96EP0;
803-806
100
Human p97 double hexamer conformer II with ATPgammaS boundhomo-12-mer12-777
10024×AGS; 12×MG;
Human p97 double hexamer conformer I with D1-ATPgammaS and D2-ADP boundhomo-12-mer21-777
10012×AGS; 12×MG; 12×ADP;
Cryo-EM structure of human p97 bound to CB-5083 and ADP.homo-12-mer21-775
100.012×JDP; 12×ADP;
Cryo-EM structure of dodecamer P97homo-12-mer21-775
10012×ADP; 12×Y6Y;
Structure of VCP dodecamer purified from H1299 cellshomo-12-mer22-775
100.0
Structure of apo VCP dodecamer generated from bacterially recombinant VCP/p97homo-12-mer22-775
99.86
Human p97/VCP structure with a triazole inhibitor (NSC799462/dodecamer)homo-12-mer22-775
100.024×ADP; 12×XKM;
Cryo-EM structure of human p97 bound to CB-5083 and ATPgS.homo-12-mer21-768
100.012×AGS; 12×MG; 12×JDP;
p97-R155H mutant dodecamer Ihomo-12-mer196-773
100.0
p97-R155H mutant dodecamer IIhomo-12-mer201-762
100.0
p97 D1D2 with CB5083 boundhomo-12-mer210-763
100.012×JDP;
Structure of VCP in complex with an ATPase activator (D2 domains only, dodecameric form)homo-12-mer466-775
100.012×A1AC1;
Structure of D2 subdomain of P97/VCP in complex with ADPhomo-7-mer463-763
100.0ADP;
Cryo-EM structure of human p97 in complex with NMS-873 in the presence of ATP, Npl4/Ufd1, and Ub6homo-6-mer12-775
99.7312×ATP;Y6Y; 12×MG;
Cryo-EM structure of human p97-R191Q mutant bound to ADP.homo-6-mer12-775
99.8712×ADP;
Cryo-EM structure of human p97 in complex with Npl4/Ufd1 and Ub6 (Class 2)homo-6-mer12-775
99.73ADP;ATP;MG;
Cryo-EM structure of human p97 in complex with Npl4/Ufd1 and Ub6 (Class 1)homo-6-mer12-775
99.73ADP;ATP;MG;
Cryo-EM structure of human p97 in complex with Npl4/Ufd1 and Ub6 (Class 3)homo-6-mer12-775
99.73ADP;ATP;MG;
Human p97 single hexamer conformer I with ATPgammaS boundhomo-6-mer12-769
10012×AGS; 12×MG;
Cryo-EM structure of human p97-R191Q mutant bound to ATPgS.homo-6-mer12-768
99.8612×AGS; 12×MG;
Cryo-EM structure of human p97-R155H mutant bound to ATPgS.homo-6-mer12-768
99.8612×AGS; 12×MG;
Cryo-EM structure of human p97-A232E mutant bound to ATPgS.homo-6-mer12-768
99.8612×AGS; 12×MG;
Structure of human p97 in complex with ATPgammaS and Npl4/Ufd1 (masked around p97)homo-6-mer12-768
100.012×MG; 12×AGS;
Cryo-EM structure of human p97 bound to ATPgS (Conformation III)homo-6-mer12-768
100.012×AGS; 12×MG;
Cryo-EM structure of human p97-D592N mutant bound to ADP.homo-6-mer21-775
99.8612×ADP;
Cryo-EM structure of human p97-R155H mutant bound to ADP.homo-6-mer21-775
99.8612×ADP;
Cryo-EM structure of human p97-A232E mutant bound to ADPhomo-6-mer21-775
99.8612×ADP;
Cryo-EM structure of human p97-E470D mutant bound to ADP.homo-6-mer21-775
99.8612×ADP;
p97 (VCP) mutant - F266Ahomo-6-mer21-774
99.87
Structure of apo VCP hexamer generated from bacterially recombinant VCP/p97homo-6-mer22-775
99.86
Human p97/VCP structure with a triazole inhibitor (NSC799462/hexamer)homo-6-mer22-775
100.012×ADP;XKM;
Full composite cryo-EM map of p97/VCP in ADP.Pi statehomo-6-mer22-775
100.0ADP;ATP; 12×MG;K;PO4;
p97-delta709-728 in complex with ATP-gamma-Shomo-6-mer20-770
100.012×AGS; 12×MG;CL;
Human p97 single hexamer conformer III with D1-ATPgammaS and D2-ADP boundhomo-6-mer21-771
100AGS;MG;ADP;
Human p97/VCP R155H mutant structure with a triazole inhibitor (NSC819701/down)homo-6-mer22-772
99.8712×ADP;XO8;
p97-N750D/R753D/M757D/Q760D in complex with ATP-gamma-Shomo-6-mer21-770
99.4612×AGS; 12×MG;
Human p97 single hexamer conformer II with ATPgammaS boundhomo-6-mer21-770
100.012×AGS; 12×MG;
Human AAA+ ATPase VCP mutant - T76A, AMP-PNP-bound form, Conformation Ihomo-6-mer18-766
99.86ADP;ANP;
Cryo-EM structure of human p97-D592N mutant bound to ATPgS.homo-6-mer21-768
99.8612×AGS; 12×MG;
Cryo-EM structure of human p97-E470D mutant bound to ATPgS.homo-6-mer21-768
99.8612×AGS; 12×MG;
Cryo-EM structure of human p97 bound to ATPgS (Conformation II)homo-6-mer21-768
100.0AGS;ADP;MG;
Human AAA+ ATPase VCP mutant - T76E, ADP-bound formhomo-6-mer20-766
99.8612×ADP;
Human AAA+ ATPase VCP mutant - T76A, ADP-bound formhomo-6-mer20-766
99.8612×ADP;
Human AAA+ ATPase VCP mutant - T76E, AMP-PNP bound form, Conformation Ihomo-6-mer20-766
99.86ADP;ANP;
p97 (VCP) mutant - F539Ahomo-6-mer21-766
99.8710×ADP;
p97 (VCP) mutant - F539A state IIIhomo-6-mer21-766
99.87ATP; 11×ADP;
Structure of P97/vcp in complex with ADPhomo-6-mer21-763
100.012×ADP;
Structure of P97/vcp in complex with ADP/ADP.alfxhomo-6-mer21-763
100.012×ADP;AF3;
p97 (VCP) double mutant - F266A F539Ahomo-6-mer21-763
99.73
Cryo-EM structure of human p97 bound to UPCDC30245 inhibitorhomo-6-mer21-763
100.012×ADP;OJA;
Cryo-EM structure of human p97 bound to ADPhomo-6-mer21-763
100.012×ADP;
Cryo-EM structure of human p97 bound to ATPgS (Conformation I)homo-6-mer21-763
100.012×ADP;
p97 (VCP) mutant - F539A ADP statehomo-6-mer21-762
99.8612×ADP;
Structure of P97/vcp in complex with ADP/AMP-PNPhomo-6-mer21-759
100.0ADP;ANP;
The crystal structure of murine p97/VCP at 3.6Ahomo-6-mer17-735
99.85ADP;
Structure of human p97 ATPase L464P mutanthomo-6-mer195-763
99.81ADP;
Human p97/VCP R155H mutant structure with a triazole inhibitor (NSC819701/up)homo-6-mer196-761
100.012×ADP;XO8;
D1 and D2 domain structure of the p97(R155H)-p47 complexhomo-6-mer199-764
100.0
Human p97/VCP R155H mutant structure with a triazole inhibitor (NSC804515)homo-6-mer200-763
100.012×ADP;XNU;
Structure of p97 N-D1 R155H mutant in complex with ATPgShomo-6-mer14-469
99.78AGS;MG;
Structure of p97 N-D1 R155H mutant in complex with ATPgShomo-6-mer17-469
99.78AGS;MG;
Structure of p97 N-D1 R86A mutant in complex with ATPgShomo-6-mer12-463
99.78AGS;MG;
Structure of p97 N-D1 A232E mutant in complex with ATPgShomo-6-mer12-462
99.78AGS;MG;
Structure of p97 N-D1 R95G mutant in complex with ATPgShomo-6-mer12-462
99.78AGS;MG;
Structure of p97 N-D1(L198W) in complex with Fragment TROLL2homo-6-mer15-460
99.77ADP; 96×FMT;6LY;PEG;NA;
Structure of p97 N-D1 L198W mutant in complex with ADPhomo-6-mer15-460
99.78ADP;
Structure of p97 N-D1 R155H mutant in complex with ADPhomo-6-mer21-461
99.77ADP;
Structure of p97 N-D1 wild-type in complex with ADPhomo-6-mer21-460
100ADP;
Structure of the N-Terminal domain and the D1 AAA domain of membrane fusion ATPase p97homo-6-mer21-458
99.77ADP;
Structure of VCP in complex with an ATPase activator (D2 domains only, hexameric form)homo-6-mer466-775
100.0A1AC1;
Structure of VCP in complex with an ATPase activator and ADP (D2 domains only, hexameric form)homo-6-mer466-774
100.0ADP;A1AC1;
Crystal structure of the p97 D2 domain in a helical split-washer conformationmonomer468-764
100MPD;DMS;ADP;
Crystal structure of the p97 D2 domain in a helical split-washer conformationmonomer468-764
100.0MPD;DMS;EJQ;ADP;NA;
Crystal structure of the p97 D2 domain in a helical split-washer conformationmonomer468-763
100.0MPD;DMS;ADP;NA;EJW;
Crystal structure of the p97 D2 domain in a helical split-washer conformationmonomer468-763
100.0MPD;DMS;ADP;NA;ELQ;
Crystal structure of the p97 D2 domain in a helical split-washer conformationmonomer468-763
100.0MPD;DMS;ADP;NA;ELN;
Crystal structure of the p97 D2 domain in a helical split-washer conformationmonomer468-763
100.0MPD;DMS;ADP;NA;AWD;
Crystal Structure of the p97 N-terminal domainmonomer20-187
100HEZ;GOL;CO;CL;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8fcl.1.Emonomer0.7723-763
ADP;100.00